200 related articles for article (PubMed ID: 17433696)
1. Scaffold hopping, synthesis and structure-activity relationships of 5,6-diaryl-pyrazine-2-amide derivatives: a novel series of CB1 receptor antagonists.
Boström J; Berggren K; Elebring T; Greasley PJ; Wilstermann M
Bioorg Med Chem; 2007 Jun; 15(12):4077-84. PubMed ID: 17433696
[TBL] [Abstract][Full Text] [Related]
2. Novel thioamide derivatives as neutral CB1 receptor antagonists.
Boström J; Olsson RI; Tholander J; Greasley PJ; Ryberg E; Nordberg H; Hjorth S; Cheng L
Bioorg Med Chem Lett; 2010 Jan; 20(2):479-82. PubMed ID: 20005704
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacological evaluation of novel octahydro-1H-pyrido[1,2-a]pyrazine as mu-opioid receptor antagonists.
Le Bourdonnec B; Goodman AJ; Graczyk TM; Belanger S; Seida PR; DeHaven RN; Dolle RE
J Med Chem; 2006 Dec; 49(25):7290-306. PubMed ID: 17149859
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of piperazine analogues as CB1 cannabinoid receptor ligands.
Song KS; Lee SH; Chun HJ; Kim JY; Jung ME; Ahn K; Kim SU; Kim J; Lee J
Bioorg Med Chem; 2008 Apr; 16(7):4035-51. PubMed ID: 18243711
[TBL] [Abstract][Full Text] [Related]
5. Diarylimidazolyl oxadiazole and thiadiazole derivatives as cannabinoid CB1 receptor antagonists.
Kim JY; Seo HJ; Lee SH; Jung ME; Ahn K; Kim J; Lee J
Bioorg Med Chem Lett; 2009 Jan; 19(1):142-5. PubMed ID: 19022666
[TBL] [Abstract][Full Text] [Related]
6. Keynote review: Medicinal chemistry strategies to CB1 cannabinoid receptor antagonists.
Lange JH; Kruse CG
Drug Discov Today; 2005 May; 10(10):693-702. PubMed ID: 15896682
[TBL] [Abstract][Full Text] [Related]
7. Novel 3,4-diarylpyrazolines as potent cannabinoid CB1 receptor antagonists with lower lipophilicity.
Lange JH; van Stuivenberg HH; Veerman W; Wals HC; Stork B; Coolen HK; McCreary AC; Adolfs TJ; Kruse CG
Bioorg Med Chem Lett; 2005 Nov; 15(21):4794-8. PubMed ID: 16140010
[TBL] [Abstract][Full Text] [Related]
8. Chemical and biological investigation of cyclopropyl containing diaryl-pyrazole-3-carboxamides as novel and potent cannabinoid type 1 receptor antagonists.
Szabó G; Varga B; Páyer-Lengyel D; Szemzo A; Erdélyi P; Vukics K; Szikra J; Hegyi E; Vastag M; Kiss B; Laszy J; Gyertyán I; Fischer J
J Med Chem; 2009 Jul; 52(14):4329-37. PubMed ID: 19527048
[TBL] [Abstract][Full Text] [Related]
9. Biarylpyrazolyl oxadiazole as potent, selective, orally bioavailable cannabinoid-1 receptor antagonists for the treatment of obesity.
Lee SH; Seo HJ; Lee SH; Jung ME; Park JH; Park HJ; Yoo J; Yun H; Na J; Kang SY; Song KS; Kim MA; Chang CH; Kim J; Lee J
J Med Chem; 2008 Nov; 51(22):7216-33. PubMed ID: 18954042
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, biological evaluation, and comparative docking study of 1,2,4-triazolones as CB1 receptor selective antagonists.
Han S; Zhang FF; Xie X; Chen JZ
Eur J Med Chem; 2014 Mar; 74():73-84. PubMed ID: 24445310
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and SAR of 1,4,5,6-tetrahydropyridazines as potent cannabinoid CB1 receptor antagonists.
Lange JH; den Hartog AP; van der Neut MA; van Vliet BJ; Kruse CG
Bioorg Med Chem Lett; 2009 Oct; 19(19):5675-8. PubMed ID: 19699640
[TBL] [Abstract][Full Text] [Related]
12. Discovery of pyrazine carboxamide CB1 antagonists: the introduction of a hydroxyl group improves the pharmaceutical properties and in vivo efficacy of the series.
Ellsworth BA; Wang Y; Zhu Y; Pendri A; Gerritz SW; Sun C; Carlson KE; Kang L; Baska RA; Yang Y; Huang Q; Burford NT; Cullen MJ; Johnghar S; Behnia K; Pelleymounter MA; Washburn WN; Ewing WR
Bioorg Med Chem Lett; 2007 Jul; 17(14):3978-82. PubMed ID: 17513109
[TBL] [Abstract][Full Text] [Related]
13. Diaryl piperidines as CB1 receptor antagonists.
Scott JD; Li SW; Wang H; Xia Y; Jayne CL; Miller MW; Duffy RA; Boykow GC; Kowalski TJ; Spar BD; Stamford AW; Chackalamannil S; Lachowicz JE; Greenlee WJ
Bioorg Med Chem Lett; 2010 Feb; 20(3):1278-83. PubMed ID: 20018510
[TBL] [Abstract][Full Text] [Related]
14. Studies on pyrazine derivatives. XLVII. Synthesis and antibacterial activity of novel pyrazine derivatives with amidoxime moiety.
Gobis K; Foks H; Kedzia A; Wierzchowska M; Kwapisz E; Zwolska Z; Augustynowicz-Kopeć E
Acta Pol Pharm; 2006; 63(1):39-45. PubMed ID: 17515328
[TBL] [Abstract][Full Text] [Related]
15. Discovery of 1-[9-(4-chlorophenyl)-8-(2-chlorophenyl)-9H-purin-6-yl]-4-ethylaminopiperidine-4-carboxylic acid amide hydrochloride (CP-945,598), a novel, potent, and selective cannabinoid type 1 receptor antagonist.
Griffith DA; Hadcock JR; Black SC; Iredale PA; Carpino PA; DaSilva-Jardine P; Day R; DiBrino J; Dow RL; Landis MS; O'Connor RE; Scott DO
J Med Chem; 2009 Jan; 52(2):234-7. PubMed ID: 19102698
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and c-Src inhibitory activity of imidazo[1,5-a]pyrazine derivatives as an agent for treatment of acute ischemic stroke.
Mukaiyama H; Nishimura T; Kobayashi S; Ozawa T; Kamada N; Komatsu Y; Kikuchi S; Oonota H; Kusama H
Bioorg Med Chem; 2007 Jan; 15(2):868-85. PubMed ID: 17095233
[TBL] [Abstract][Full Text] [Related]
17. Exploring SAR features in diverse library of 4-cyanomethyl-pyrazole-3-carboxamides suitable for further elaborations as CB1 antagonists.
Cooper M; Receveur JM; Bjurling E; Nørregaard PK; Nielsen PA; Sköld N; Högberg T
Bioorg Med Chem Lett; 2010 Jan; 20(1):26-30. PubMed ID: 19954978
[TBL] [Abstract][Full Text] [Related]
18. Insights into the molecular requirements for the anti-obesity activity of a series of CB1 ligands.
Weber KC; De Lima EF; De Mello PH; Da Silva AB; Honório KM
Chem Biol Drug Des; 2010 Oct; 76(4):320-9. PubMed ID: 20887613
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship studies of novel pyrazole and imidazole carboxamides as cannabinoid-1 (CB1) antagonists.
Sasmal PK; Talwar R; Swetha J; Balasubrahmanyam D; Venkatesham B; Rawoof KA; Neelima Devi B; Jadhav VP; Khan SK; Mohan P; Srinivasa Reddy D; Nyavanandi VK; Nanduri S; Kyasa SK; Kannan M; Srinivas P; Nadipalli P; Chaudhury H; Sebastian VJ
Bioorg Med Chem Lett; 2011 Aug; 21(16):4913-8. PubMed ID: 21741835
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity studies on diphenylpyrazine derivatives: a novel class of prostacyclin receptor agonists.
Asaki T; Hamamoto T; Sugiyama Y; Kuwano K; Kuwabara K
Bioorg Med Chem; 2007 Nov; 15(21):6692-704. PubMed ID: 17764960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
